Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7981)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2013 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xanthoulis A, Tiniakos DG. E2F transcription factors and digestive system malignancies: How much do we know? World J Gastroenterol 2013; 19(21): 3189-3198 [PMID: 23745020 DOI: 10.3748/wjg.v19.i21.3189] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i21/3189.htm |
| Number | Citing Articles |
| 1 |
Konstantinos Evangelou, Sophia Havaki, Athanassios Kotsinas. E2F transcription factors and digestive system malignancies: How much do we know?. World Journal of Gastroenterology 2014; 20(29): 10212-10216 doi: 10.3748/wjg.v20.i29.10212
|
| 2 |
Pengfei Li, Huina Lv, Yongkai Wu, Ke Xu, Min Xu, Yegang Ma. E2F transcription factor 1 is involved in the phenotypic modulation of esophageal squamous cell carcinoma cells via microRNA-375. Bioengineered 2021; 12(2): 10047 doi: 10.1080/21655979.2021.1996510
|
| 3 |
ZhaoHui Xu, Hui Qu, YanYing Ren, ZeZhong Gong, Hyok Ju Ri, Xin Chen. An Update on the Potential Roles of E2F Family Members in Colorectal Cancer. Cancer Management and Research 2021; : 5509 doi: 10.2147/CMAR.S320193
|
| 4 |
Uday Sankar Allam, Shilpa Kamatham, Maraline Adarsha, Sk. Md. Jasmine, P. V. Giri Prasad. Role of Transcription Factors in Gastrointestinal Malignancies. 2017; : 215 doi: 10.1007/978-981-10-6728-0_15
|
| 5 |
Tianyi Wu, Lizhao Wu. The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.655630
|
| 6 |
Zhilu Gan, Alimujiang Abudurexiti, Xiaogang Hu, Wenxin Chen, Ning Zhang, Wei Sang. E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer. Medicine 2024; 103(2): e35722 doi: 10.1097/MD.0000000000035722
|
| 7 |
Ying Yuan, Erich M. Sturgis, Lijun Zhu, Meixia Lu, Yuncheng Li, Qingyi Wei, Guojun Li. A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma. Molecular Carcinogenesis 2017; 56(3): 1100 doi: 10.1002/mc.22576
|
| 8 |
Shika Hanif Malgundkar, Ikram Burney, Mansour Al Moundhri, Moza Al Kalbani, Ritu Lakhtakia, Aikou Okamoto, Yahya Tamimi. E2F5 Promotes the Malignancy of Ovarian Cancer Via the Regulation of Hippo and Wnt Pathways. Genetic Testing and Molecular Biomarkers 2021; 25(3): 179 doi: 10.1089/gtmb.2020.0166
|
| 9 |
Patrick D. Wilkinson, Evan R. Delgado, Frances Alencastro, Madeleine P. Leek, Nairita Roy, Matthew P. Weirich, Elizabeth C. Stahl, P. Anthony Otero, Maelee I. Chen, Whitney K. Brown, Andrew W. Duncan. The Polyploid State Restricts Hepatocyte Proliferation and Liver Regeneration in Mice. Hepatology 2019; 69(3): 1242 doi: 10.1002/hep.30286
|
| 10 |
Xiaofeng Han, Jie Chen. KAT2A affects tumor metabolic reprogramming in colon cancer progression through epigenetic activation of E2F1. Human Cell 2022; 35(4): 1140 doi: 10.1007/s13577-022-00707-3
|
| 11 |
Bin Li, Wen Wen Xu, Xin Yuan Guan, Yan Ru Qin, Simon Law, Nikki Pui Yue Lee, Kin Tak Chan, Pui Ying Tam, Yuk Yin Li, Kwok Wah Chan, Hiu Fung Yuen, Sai Wah Tsao, Qing Yu He, Annie L.M. Cheung. Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance. Clinical Cancer Research 2016; 22(5): 1243 doi: 10.1158/1078-0432.CCR-15-1196
|
| 12 |
Dan Xie, Qin Pei, Jingyuan Li, Xue Wan, Ting Ye. Emerging Role of E2F Family in Cancer Stem Cells. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.723137
|
| 13 |
Justin T. Huntington, Xing Tang, Lindsey N. Kent, Carl R. Schmidt, Gustavo Leone. The Spectrum of E2F in Liver Disease-Mediated Regulation in Biology and Cancer. Journal of Cellular Physiology 2016; 231(7): 1438 doi: 10.1002/jcp.25242
|
| 14 |
Fei-Fei Liu, Kai-Ling Wang, Li-Ping Deng, Xiao Liu, Min-yuan Wu, Tian-You Wang, Lei Cui, Zhi-Gang Li. Transcription factor E2F3a regulates CASP8AP2 transcription and enhances sensitivity to chemotherapeutic drugs in acute lymphoblastic leukemia. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0531-1
|
| 15 |
Lei Zhan, Cheng Huang, Xiao Ming Meng, Yang Song, Xiao Qin Wu, Cheng Gui Miu, Xiang Shu Zhan, Jun Li. Promising roles of mammalian E2Fs in hepatocellular carcinoma. Cellular Signalling 2014; 26(5): 1075 doi: 10.1016/j.cellsig.2014.01.008
|
| 16 |
Yating Ma, Shijian Wang, Jinfeng Bao, Chengbin Wang. Systematic study on expression and prognosis of E2Fs in human colorectal cancer. International Journal of Clinical Oncology 2022; 27(2): 362 doi: 10.1007/s10147-021-02051-2
|
| 17 |
Pål Vange, Torunn Bruland, Vidar Beisvag, Sten Even Erlandsen, Arnar Flatberg, Berit Doseth, Arne K Sandvik, Ingunn Bakke. Genome‐wide analysis of the oxyntic proliferative isthmus zone reveals ASPM as a possible gastric stem/progenitor cell marker over‐expressed in cancer. The Journal of Pathology 2015; 237(4): 447 doi: 10.1002/path.4591
|
| 18 |
Jung Nyeo Chun, Minsoo Cho, Soonbum Park, Insuk So, Ju-Hong Jeon. The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(1): 188336 doi: 10.1016/j.bbcan.2019.188336
|
| 19 |
ZhaoHui Xu, Hui Qu, YanYing Ren, ZeZhong Gong, Hyok Ju Ri, Fan Zhang, Shuai Shao, XiaoLiang Chen, Xin Chen. Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis. International Journal of General Medicine 2022; : 4849 doi: 10.2147/IJGM.S352141
|
| 20 |
Xiaoyan Fan, Yitao Wang, Tinghui Jiang, Tao Liu, Yuelei Jin, Kailong Du, Yulong Niu, Chunxue Zhang, Zhongyu Liu, Yunlong Lei, Youquan Bu. B-Myb accelerates colorectal cancer progression through reciprocal feed-forward transactivation of E2F2. Oncogene 2021; 40(37): 5613 doi: 10.1038/s41388-021-01961-9
|
| 21 |
Fanni Li, Jun Yan, Jing Leng, Tianyu Yu, Huayou Zhou, Chang Liu, Wenbo Huang, Qi Sun, Wei Zhao. Expression patterns of E2Fs identify tumor microenvironment features in human gastric cancer. PeerJ 2024; 12: e16911 doi: 10.7717/peerj.16911
|
| 22 |
Kirsten Nguyen Knudsen, Boye Schnack Nielsen, Jan Lindebjerg, Torben Frøstrup Hansen, René Holst, Flemming Brandt Sørensen, Jin Q. Cheng. microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution. PLOS ONE 2015; 10(10): e0140503 doi: 10.1371/journal.pone.0140503
|
| 23 |
Thaís Brilhante Pontes, Elizabeth Suchi Chen, Carolina Oliveira Gigek, Danielle Queiroz Calcagno, Fernanda Wisnieski, Mariana Ferreira Leal, Samia Demachki, Paulo Pimentel Assumpção, Ricardo Artigiani, Laércio Gomes Lourenço, Rommel Rodriguez Burbano, Marília Arruda Cardoso Smith. Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis. Tumor Biology 2014; 35(4): 3447 doi: 10.1007/s13277-013-1455-y
|
| 24 |
Jiadong Chu, Na Sun, Wei Hu, Xuanli Chen, Nengjun Yi, Yueping Shen, Andy T. Y. Lau. Bayesian hierarchical lasso Cox model: A 9-gene prognostic signature for overall survival in gastric cancer in an Asian population. PLOS ONE 2022; 17(4): e0266805 doi: 10.1371/journal.pone.0266805
|
| 25 |
Bertrand De Meulder, Diane Lefaudeux, Aruna T. Bansal, Alexander Mazein, Amphun Chaiboonchoe, Hassan Ahmed, Irina Balaur, Mansoor Saqi, Johann Pellet, Stéphane Ballereau, Nathanaël Lemonnier, Kai Sun, Ioannis Pandis, Xian Yang, Manohara Batuwitage, Kosmas Kretsos, Jonathan van Eyll, Alun Bedding, Timothy Davison, Paul Dodson, Christopher Larminie, Anthony Postle, Julie Corfield, Ratko Djukanovic, Kian Fan Chung, Ian M. Adcock, Yi-Ke Guo, Peter J. Sterk, Alexander Manta, Anthony Rowe, Frédéric Baribaud, Charles Auffray. A computational framework for complex disease stratification from multiple large-scale datasets. BMC Systems Biology 2018; 12(1) doi: 10.1186/s12918-018-0556-z
|
| 26 |
Daojiang Li, Changwei Lin, Nanpeng Li, Yuheng Du, Chunxing Yang, Yang Bai, Zhicai Feng, Chen Su, Runliu Wu, Shenglei Song, Peicheng Yan, Miao Chen, Arad Jain, Lihua Huang, Yi Zhang, Xiaorong Li. PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness. EBioMedicine 2019; 45: 124 doi: 10.1016/j.ebiom.2019.06.051
|
| 27 |
Yicai Zheng, He Fei, Satoshi Maruyama. High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4731364
|
| 28 |
Wang-Yang Ye, Hui-Ping Lu, Jian-Di Li, Gang Chen, Rong-Quan He, Hua-Yu Wu, Xian-Guo Zhou, Min-Hua Rong, Li-Hua Yang, Wei-Ying He, Qiu-Yu Pang, Shang-Ling Pan, Yu-Yan Pang, Yi-Wu Dang. Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma Tissues. Cancer Biotherapy and Radiopharmaceuticals 2023; 38(10): 684 doi: 10.1089/cbr.2020.4342
|
| 29 |
Yan Fu, Cheng’en Hu, Peizhun Du, Guangjian Huang, Jie Mei. E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/6611327
|
| 30 |
Susanna Cogoi, Valentina Rapozzi, Sabina Cauci, Luigi E. Xodo. Critical role of hnRNP A1 in activating KRAS transcription in pancreatic cancer cells: A molecular mechanism involving G4 DNA. Biochimica et Biophysica Acta (BBA) - General Subjects 2017; 1861(5): 1389 doi: 10.1016/j.bbagen.2016.11.031
|
| 31 |
Alireza Korourian, Raheleh Roudi, Ahmad Shariftabrizi, Elham Kalantari, Kambiz Sotoodeh, Zahra Madjd. Differential role of Wnt signaling and base excision repair pathways in gastric adenocarcinoma aggressiveness. Clinical and Experimental Medicine 2017; 17(4): 505 doi: 10.1007/s10238-016-0443-0
|
| 32 |
Maria A Dosil, Raúl Navaridas, Cristina Mirantes, Jordi Tarragona, Núria Eritja, Isidre Felip, Izaskun Urdanibia, Cristina Megino, Mónica Domingo, Maria Santacana, Sònia Gatius, Carme Piñol, Carla Barceló, Oscar Maiques, Anna Macià, Ana Velasco, Marta Vaquero, Xavier Matias‐Guiu, Xavier Dolcet. Tumor suppressive function of E2F‐1 on PTEN‐induced serrated colorectal carcinogenesis. The Journal of Pathology 2019; 247(1): 72 doi: 10.1002/path.5168
|
| 33 |
Theasha Manicum, Fubiao Ni, Yiming Ye, Xuhui Fan, Bi-Cheng Chen. Prognostic values of E2F mRNA expression in human gastric cancer. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20181264
|
| 34 |
|
| 35 |
Haibo Yao, Fang Lu, Yanfei Shao. The E2F family as potential biomarkers and therapeutic targets in colon cancer. PeerJ 2020; 8: e8562 doi: 10.7717/peerj.8562
|
| 36 |
Tong Li, Jue Yang, Xiaobo Lv, Kunmei Liu, Chao Gao, Yingying Xing, Tao Xi. miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2. Biotechnology Letters 2014; 36(9): 1743 doi: 10.1007/s10529-014-1540-3
|
| 37 |
Martin Triska, Alexander Ivliev, Yuri Nikolsky, Tatiana V. Tatarinova. Biological Networks and Pathway Analysis. Methods in Molecular Biology 2017; 1613: 291 doi: 10.1007/978-1-4939-7027-8_11
|
| 38 |
Ya Li, Lingqun Zhu, Fengqin Shi, Ruibai Li, Xinyi Chen, Zhi Zheng, Bin Qiu, Li Hou. Modified Liangfu granule exhibits anti-cancer effects in gastric cancer by regulating apoptosis-related proteins and genes. Journal of Traditional Chinese Medical Sciences 2019; 6(4): 325 doi: 10.1016/j.jtcms.2019.11.002
|
| 39 |
Christophe Chapard, Daniel Hohl, Marcel Huber. The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis. Oncotarget 2015; 6(25): 20933 doi: 10.18632/oncotarget.3055
|
| 40 |
Breanne C. Morrell, Lingna Zhang, Luis F. Schütz, M. Chiara Perego, Excel Rio S. Maylem, Leon J. Spicer. Regulation of the transcription factor E2F8 gene expression in bovine ovarian cells. Molecular and Cellular Endocrinology 2019; 498: 110572 doi: 10.1016/j.mce.2019.110572
|
| 41 |
Rashmi Nagesh, Rajeshwari H. Patil, M. Naveen Kumar, K.M. Kiran Kumar, Shivaleela Biradar, Babu R. Lamani. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 165 doi: 10.1016/B978-0-323-98807-0.00014-4
|
| 42 |
Zhao-Shan Fang, Zhi Zhang, Zhi-Jie Liang, Zhong-Rong Long, Yi Xiao, Zhi-Yin Liang, Xing Sun, Hong-Mian Li, Hai Huang. Liquid–Liquid Phase Separation-Related Genes Associated with Tumor Grade and Prognosis in Hepatocellular Carcinoma: A Bioinformatic Study. International Journal of General Medicine 2021; : 9671 doi: 10.2147/IJGM.S342602
|
| 43 |
Zhaoyang Yan, Tongxin Xu, Juntao Lu, Zheng Wu, Xiaoxu Li, Jinsheng Xu, Wei Guo, Zhiming Dong. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway. Pathology - Research and Practice 2022; 236: 153963 doi: 10.1016/j.prp.2022.153963
|
| 44 |
Tong Li, Wenjing Luo, Kunmei Liu, Xiaobo Lv, Tao Xi. miR-31 promotes proliferation of colon cancer cells by targeting E2F2. Biotechnology Letters 2015; 37(3): 523 doi: 10.1007/s10529-014-1715-y
|
| 45 |
Meiyin Zhang, Ye Xu, Yongjian Zhang, Bing Li, Ge Lou. Circular RNA circE2F2 promotes malignant progression of ovarian cancer cells by upregulating the expression of E2F2 protein via binding to HuR protein. Cellular Signalling 2021; 84: 110014 doi: 10.1016/j.cellsig.2021.110014
|
| 46 |
Rossella Farra, Barbara Dapas, Daniele Baiz, Federica Tonon, Sara Chiaretti, Giannino Del Sal, Alessandra Rustighi, Nicola Elvassore, Gabriele Pozzato, Mario Grassi, Gabriele Grassi. Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells. Biochimie 2015; 112: 85 doi: 10.1016/j.biochi.2015.02.015
|
| 47 |
Ying Lü, Jing Zhang, Lei Li, Shun Li, Zongguo Yang. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report. Bioscience Reports 2020; 40(2) doi: 10.1042/BSR20193212
|
| 48 |
Qinyang Xu, Qiulin Ge, Yang Zhou, Bikang Yang, Qin Yang, Shuheng Jiang, Rongzhen Jiang, Zhihong Ai, Zhigang Zhang, Yincheng Teng. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway. EBioMedicine 2020; 51: 102609 doi: 10.1016/j.ebiom.2019.102609
|
| 49 |
Shouping Wang, Kun Cao, Yuting Liao, Wei Zhang, Jihua Zheng, Xiaocui Li, Mengting Huang, Yonghao Zhong, Xiao Hu, De Chen, Yanjie Wang. CDCA2 protects against oxidative stress by promoting BRCA1–NRF2 signaling in hepatocellular carcinoma. Oncogene 2021; 40(25): 4368 doi: 10.1038/s41388-021-01855-w
|
| 50 |
Quan Zhou, Fan Zhang, Ze He, Man-Zhen Zuo. E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00161
|
| 51 |
Manaswini Gattupalli, Parry Dey, Shanmugam Poovizhi, Riya Ben Patel, Debasish Mishra, Satarupa Banerjee. Regenerative Medicine. 2023; : 331 doi: 10.1007/978-981-19-6008-6_16
|
| 52 |
Takenori Yamauchi, Shouhei Takeuchi, Naoki Maehara, Yoshiki Kuroda. The genotype of the transporter associated with antigen processing gene affects susceptibility to colorectal cancer in Japanese. Environmental Health and Preventive Medicine 2014; 19(4): 265 doi: 10.1007/s12199-014-0388-4
|
| 53 |
Meiyin Zhang, Ye Xu, Yongjian Zhang, Ge Lou. E2F8 knockdown suppresses cell proliferation and induces cell cycle arrest via Wnt/β-Catenin pathway in ovarian cancer. Chinese Journal of Physiology 2023; 66(4): 266 doi: 10.4103/cjop.CJOP-D-22-00142
|
| 54 |
Fumiyoshi Saito, Kenichiro Araki, Takehiko Yokobori, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norio Kubo, Bolag Altan, Ken Shirabe, Hiroyuki Kuwano. High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction. Journal of Surgical Oncology 2016; 114(4): 462 doi: 10.1002/jso.24330
|
| 55 |
Jiang Du, Lin Zhang. Analysis of salivary microRNA expression profiles and identification of novel biomarkers in esophageal cancer. Oncology Letters 2017; 14(2): 1387 doi: 10.3892/ol.2017.6328
|
| 56 |
GenYi Qu, Guang Yang, Dan Chen, Cheng Tang, Yong Xu. E2F2 serves as an essential prognostic biomarker and therapeutic target for human renal cell carcinoma by presenting “E2F2/miR-16–5p/SPTLC1” schema. Translational Oncology 2023; 34: 101699 doi: 10.1016/j.tranon.2023.101699
|